1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. Carasent ASA
  6. News
  7. Summary
    CARA   NO0010123060

CARASENT ASA

(CARA)
  Report
Real-time Oslo Bors  -  10:25 2022-07-01 am EDT
22.20 NOK   -0.89%
06/16Norway's Carasent Names New CEO
MT
06/16CARASENT ASA : Daniel Öhman appointed new CEO
AQ
05/20Carasent - Webdoc NO a Litmus Test for Carasent's Extensive Capex Initiatives
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Carasent : Redeye initiates coverage of Carasent

10/16/2020 | 02:00am EDT

Redeye initiates coverage of Carasent, the Norwegian holding company of the electronic medical record (EMR) developer Evimeria. This emerging compounder offers an attractive growth play on healthcare digitization with notable protection from its strong moats. Near-term catalysts include expansion to neighboring countries.

Read more and download the Research Report

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases

All news about CARASENT ASA
06/16Norway's Carasent Names New CEO
MT
06/16CARASENT ASA : Daniel Öhman appointed new CEO
AQ
05/20Carasent - Webdoc NO a Litmus Test for Carasent's Extensive Capex Initiatives
AQ
04/28Carasent ASA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/28CARASENT : Minutes from Annual Shareholder Meeting
AQ
04/28Norway's Carasent Drops 6% as CEO Plans Exit
MT
04/28CARASENT : Q1 2022 Financial Result Presentation
AQ
04/28Carasent ASA Reiterates Earnings Guidance for the Year 2022
CI
04/28TRANSCRIPT : Carasent ASA, Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28CARASENT : CEO Dennis Højer to step down
AQ
More news
Financials
Sales 2022 198 M 19,9 M 19,9 M
Net income 2022 36,7 M 3,69 M 3,69 M
Net cash 2022 738 M 74,0 M 74,0 M
P/E ratio 2022 48,3x
Yield 2022 -
Capitalization 1 765 M 177 M 177 M
EV / Sales 2022 5,19x
EV / Sales 2023 4,05x
Nbr of Employees 129
Free-Float 70,1%
Chart CARASENT ASA
Duration : Period :
Carasent ASA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARASENT ASA
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 22,20 NOK
Average target price 46,50 NOK
Spread / Average Target 109%
EPS Revisions
Managers and Directors
Dennis Lennart Peter H÷jer Chief Executive Officer
Svein Martin Bj°rnstad Chief Financial Officer
Leif Claes Johan Lundqvist Chairman
Shane Smith Senior Vice President-Technology
Terje Rogne Director
Sector and Competitors
1st jan.Capi. (M$)
CARASENT ASA-40.80%177
ACCENTURE PLC-32.30%177 525
TATA CONSULTANCY SERVICES LTD.-11.32%153 711
AUTOMATIC DATA PROCESSING, INC.-14.82%89 076
INFOSYS LIMITED-21.63%78 622
VMWARE, INC.-1.57%48 070